drugset / Trial / NCT00655291

Efficacy of XP20B Following Bunionectomy Surgery

NCT00655291 ↗

Phase 3 Completed 190 enrolled Xanodyne Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if XP20B is an effective treatment for the relief of pain following bunionectomy surgery.

Timeline

Start
2008-04
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject XP20B Unknown — —

Indications

No indication recorded.